Standout Papers
- Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease (2003)
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease (2005)
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease (2012)
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease (2009)
Immediate Impact
5 by Nobel laureates 8 from Science/Nature 51 standout
Citing Papers
Microalgae‐Based Hydrogel for Inflammatory Bowel Disease and Its Associated Anxiety and Depression
2024 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Works of Maja Noman being referenced
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
2014
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Maja Noman | 6984 | 5525 | 2842 | 92 | 9.5k | |
| Jewel Johanns | 8404 | 6322 | 3381 | 116 | 10.2k | |
| Allan Olson | 8715 | 6827 | 3020 | 74 | 10.8k | |
| Filip Baert | 8376 | 6503 | 2735 | 132 | 10.7k | |
| Jacques Bélaïche | 5951 | 3900 | 3510 | 166 | 10.2k | |
| P. Rutgeerts | 7314 | 5539 | 2057 | 174 | 10.7k | |
| Walter Reinisch | 5160 | 3977 | 1744 | 69 | 6.9k | |
| Gerassimos J. Mantzaris | 7757 | 6109 | 1825 | 139 | 10.2k | |
| Douglas C. Wolf | 10569 | 8192 | 3520 | 113 | 13.0k | |
| Jean–Frédéric Colombel | 6753 | 5320 | 1574 | 69 | 8.6k | |
| Derek P. Jewell | 5525 | 4312 | 3059 | 123 | 9.6k |
All Works
Loading papers...